Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study

Author:

Abdi Amal1,Eckhardt Corien L.1,Velzen Alice S.1,Vuong Caroline1,Coppens Michiel2,Castaman Giancarlo3ORCID,Hart Dan P.4,Hermans Cedric5,Laros‐van Gorkom Britta6,Leebeek Frank W. G.7,Mancuso Maria Elisa89,Mazzucconi Maria G.10,McRae Simon11,Oldenburg Johannes12,Male Christoph13,Bom Johanna G.1415,Fijnvandraat Karin116,Gouw Samantha C.114,

Affiliation:

1. Pediatric Hematology Emma Children’s Hospital Amsterdam University Medical CenterUniversity of Amsterdam Amsterdam The Netherlands

2. Vascular Medicine Amsterdam University Medical CenterUniversity of Amsterdam Amsterdam The Netherlands

3. Oncology Center for Bleeding Disorders and Coagulation Careggi University Hospital Florence Italy

4. Barts and The London School of Medicine and Dentistry The Royal London Hospital Haemophilia CentreQMUL London UK

5. Haemostasis and Thrombosis Unit Cliniques Universitaires Saint‐LucUniversité Catholique de Louvain Brussels Belgium

6. Hematology Radboud University Medical Center Nijmegen The Netherlands

7. Hematology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands

8. Center for Thrombosis and Hemorrhagic Diseases Humanitas Clinical and Research Center Rozzano Italy

9. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy

10. Hematology Sapienza University of Rome Rome Italy

11. Hematology Launceston General Hospital Launceston Tasmania Australia

12. Institute of Experimental Haematology and Transfusion Medicine Bonn University Clinic Bonn Bonn Germany

13. Paediatrics Medical University of Vienna Vienna Austria

14. Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands

15. Center for Clinical Transfusion Research Sanquin Research Leiden The Netherlands

16. Molecular Cellular Hemostasis Sanquin Research and Landsteiner Laboratory Amsterdam The Netherlands

Funder

CSL Behring

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3